What Researchers Did
Researchers investigated the effects of hyperbaric oxygen therapy (HBOT) on serum osteoprotegerin (OPG) levels and lesion size in 23 patients with avascular necrosis of the femoral head (ANFH).
What They Found
Hyperbaric oxygen therapy (HBOT) reduced pain symptoms in all 19 patients who completed the study. HBOT significantly reduced lesion size in all stage I and II patients and in 2 of 11 stage III patients, while also increasing serum osteoprotegerin (OPG) levels.
What This Means for Canadian Patients
Canadian patients with avascular necrosis of the femoral head (ANFH) might experience reduced pain and lesion size with hyperbaric oxygen therapy (HBOT). This therapy could offer a non-surgical option to improve outcomes for those with early-stage ANFH.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada or with Canadian participants.
Study Limitations
A limitation of this study is its small sample size and the absence of a control group, which could impact the generalizability of the findings.